Showing results (2141-2150 of 6,739) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|March 28, 2022
Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current PerspectivesWilliam P Katt, Cody Aplin, Richard A CerioneOncotargets and Therapy|March 18, 2022
Undifferentiated Large Cell Carcinoma of the Thymus Associated with Plasma-Cell Type Castleman Disease-Like Reaction: A Case SeriesLihua Han, En-Hua Wang, Liang WangOncotargets and Therapy|April 11, 2022
Remarkable Response to the Triplet Combination of Olaparib with Pembrolizumab and Bevacizumab in the Third-Line Treatment of an Ovarian Clear Cell Carcinoma Patient with an ARID1A Mutation: A Case ReportYingchao Zhao, Yao JiangOncotargets and Therapy|April 11, 2022
Genetic Testing and Immunotherapy for Intracranial Inflammatory Myofibroblastic Tumor: A Case ReportXiangji Meng, Lei Zhang, Qi Wang, et al.Oncotargets and Therapy|March 22, 2022
Progression-Free Survival of a Patient with Advanced Hepatocellular Carcinoma Treated with Adoptive Cell Therapy Using Natural Killer Cells: A Case ReportGuodai Hong, Silun Xie, Zikuan Guo, et al.Oncotargets and Therapy|April 7, 2022
CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis ReprogrammingMengxuan Li, Nan Che, Yu Jin, et al.Oncotargets and Therapy|September 21, 2018
Mifepristone inhibits proliferation, migration and invasion of HUUA cells and promotes its apoptosis by regulation of FAK and PI3K/AKT signaling pathwayLin Sang, Dawei Lu, Jun Zhang, et al.Oncotargets and Therapy|September 21, 2018
Prognostic value of CD44v6 expression in breast cancer: a meta-analysisGuang-Lei Qiao, Li-Na Song, Zhou-Feng Deng, et al.Oncotargets and Therapy|September 21, 2018
Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusionLi-Zhe Zhong, Hong-Yan Xu, Zhong-Min Zhao, et al.Pageof 674